Your browser doesn't support javascript.
loading
Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant.
Bayati, Samaneh; Razani, Elham; Bashash, Davood; Safaroghli-Azar, Ava; Safa, Majid; Ghaffari, Seyed H.
Afiliação
  • Bayati S; Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences.
  • Razani E; Department of Hematology and Blood banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences.
  • Bashash D; Department of Hematology and Blood banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences.
  • Safaroghli-Azar A; Department of Hematology and Blood banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences.
  • Safa M; Cellular and Molecular Research Center.
  • Ghaffari SH; Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
Anticancer Drugs ; 29(3): 243-252, 2018 03.
Article em En | MEDLINE | ID: mdl-29389803

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Morfolinas / Neoplasias Hematológicas / Antagonistas dos Receptores de Neurocinina-1 Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Morfolinas / Neoplasias Hematológicas / Antagonistas dos Receptores de Neurocinina-1 Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article